Jove
Visualize
Contact Us

Related Experiment Videos

[Pyoderma gangrenosum--possible diagnosis in therapy-resistant wounds].

G Mørk1, N J Mørk

  • 1Hudavdelingen, Rikshospitalet, Oslo. gro.mork@rikshospitalet.no

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|December 8, 2000
PubMed
Summary

Pyoderma gangrenosum, a severe skin condition, was effectively treated in three patients using cyclosporin. This offers a new therapeutic option for this ulcerative inflammatory disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyclic photodynamic therapy delays first onset of actinic keratoses in renal transplant recipients: a 5-year randomized controlled trial with 12-month follow-up.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Associations between occupational therapy students' academic performance and their study approaches and perceptions of the learning environment.

BMC medical education·2021
Same author

Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands.

The British journal of dermatology·2013
Same author

The effect of a corticosteroid cream and a barrier-strengthening moisturizer in hand eczema. A double-blind, randomized, prospective, parallel group clinical trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2011
Same author

Proinflammatory cytokines upregulate expression of calprotectin (L1 protein, MRP-8/MRP-14) in cultured human keratinocytes.

The British journal of dermatology·2003
Same author

The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.

The British journal of dermatology·2003
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Pyoderma gangrenosum is a rare, chronic, ulcerative, and inflammatory skin disease.
  • It is frequently linked to systemic inflammatory conditions, notably inflammatory bowel disease.

Observation:

  • Diagnosis of pyoderma gangrenosum can be challenging.
  • Previous treatments including antibiotics, surgical interventions, and various wound dressings were ineffective for the reported patients.

Findings:

  • Three patients diagnosed with pyoderma gangrenosum achieved successful treatment outcomes with cyclosporin.
  • Cyclosporin demonstrated efficacy in managing the ulcerative lesions associated with pyoderma gangrenosum.

Implications:

  • Cyclosporin represents a promising therapeutic agent for pyoderma gangrenosum, particularly when standard treatments fail.

Related Experiment Videos

  • Further research into cyclosporin's role in managing pyoderma gangrenosum and associated inflammatory conditions is warranted.